NEW YORK (GenomeWeb News) – PerkinElmer said today that it has received Clinical Laboratory Improvement Amendments certification and a license from the State of Connecticut for its DNA Sequencing Services Laboratory in Branford.

PerkinElmer said that certification will enable it to expand its offerings to include clinical sequencing services for analysis of specific diseases including cancer and Mendelian diseases, as well as diagnostics services for new drugs and for pharmaceutical clinical trial studies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.